Building Blocks for COVID-19 Antiviral Drugs Identified in Rapid Study
Scientists have identified key chemical building blocks for an eventual antiviral drug against SARS-CoV-2, the virus that causes COVID-19.
University of California San Francisco
Give to UCSF
Newly Diagnosed COVID-19 Patients Needed for Antibiotic Clinical Trial
The nationwide clinical trial will assess whether the common antibiotic azithromycin can reduce hospitalization stays and death caused by the SARS-CoV-2 virus.
Recombinant Antibody Network Partners with Bristol Myers Squibb to Develop Novel Therapies
Under a new agreement, Celgene will further invest in the RAN’s state-of-the-art antibody engineering program to expand target discovery from oncology and immunology to include neurology.
How a Key Protein Juggles Multiple Demands to Keep Neurons Firing
UCSF researchers have become to the first to solve the structure of a hard-working protein that helps reload neurons for repeated firing.
Nature Publication Presents New ‘Blueprint’ Revealing How SARS-CoV-2 Virus Hijacks Human Cells
An international team of more than 120 scientists has detailed the impact of 75 over-the-counter prescription and development-stage drug compounds on SARS-CoV-2, the virus that causes COVID-19.
The Promise and Uncertainties of Antibody Testing for Coronavirus
As people around the world try to envision recovery from the COVID-19 pandemic, much attention has been paid to antibody testing as a way to identify people who have developed immunity to the virus. UCSF experts explain how antibody testing works, who it can be most useful for and why we should be cautious.
Clinical Trial Testing If Common Anti-Inflammatory Drug Reduces Hospitalization, Death Caused by Coronavirus
UCSF is recruiting newly diagnosed COVID-19 patients for a large global clinical trial testing whether the common anti-inflammatory drug colchicine can reduce hospitalization and death caused by the illness.
Unveiling How Coronavirus Hijacks Our Cells to Help Rush New Drugs to Patients
Though many hopes are hanging on the development of a vaccine or drug that targets the novel coronavirus directly, a UCSF-led team is taking an unconventional approach: target the host – in other words, you.
Cellular SOS: CRISPR Technique Reveals How Cell’s ‘Power Plants’ Activate Emergency Response
UC San Francisco researchers have finally identified the cellular circuit responsible for conveying stress signals from inside mitochondria to the integrated stress response, a discovery that may have important implications for treating the many debilitating diseases associated with mitochondrial stress.
Simple Blood Test May be Able to Diagnose Alzheimer’s Disease
A simple blood test may soon be able to diagnose patients with two common forms of dementia – Alzheimer’s disease and frontotemporal dementia – and tell the two apart.
Acid Reflux Drug Is a Surprising Candidate to Curb Preterm Birth
The study also identified 12 other FDA-approved drugs that are deemed safe in pregnancy.
